Effect of Osimertinib in Combination With Chemotherapy and Bevacizumab for Untreated Epidermal Growth Factor Receptor –Mutated Advanced Non-Small-Cell Lung Cancer: Case Report
Conclusions: The patient benefited from treatment with osimertinib in combination with chemotherapy and bevacizumab.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Alimta | Avastin | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer | Oral Cancer